An experimental procedure that uses a tube tied to the abdomen to drain blood from a catheter to a vein in a patient could help diagnose and treat patients with chronic infection, according to a new study.
The procedure is called rhinoclastosis or tissue-culture-engineered rhinostomy.
Researchers from the University of Pittsburgh and the University at Buffalo said in the study published in the journal JAMA Surgery that the procedure can help identify patients with the virus.
Researchers said the procedure is a potential treatment for many chronic viral infections including MRSA and herpes.
Rhinoviruses are caused by a group of bacteria called coronavirus, and they infect and cause chronic infections.
There are no treatments for rhinovirology.
The study found that people with rhinocrace, or chronic rhinococcal disease, are at higher risk of infection and can be difficult to treat.
The researchers say the procedure, which is currently in the development stage, could be used to improve outcomes for people with chronic infections or to help treat other infections.
Researchers say rhinoscopic catheter placement may improve treatment outcomes in people with more severe infections, like those associated with MRSA, as well as people with other chronic viral diseases, such as HIV and HCV.
Rhinocastric catheter-based surgery has been around for decades, but it has been difficult to use in patients with certain types of chronic viral illnesses, according a statement from the researchers.
“It has been a struggle to develop a surgical approach that allows us to safely and reliably deliver the rhinolacovirus-derived catheter into the bloodstream, to treat patients, and to manage their chronic viral infection,” said study lead author Dr. Yannick Bouchard, associate professor in the School of Medicine at the University, who was a researcher on the study.
Bouchard and his colleagues looked at a group who had been treated with rhinoskin grafts.
They were able to identify patients who had a higher than average risk of developing the virus in the surgical setting.
The researchers then performed catheter ablation to remove the catheter from the catheters.
They found that about 20 percent of patients who underwent the procedure had the virus cleared in their bloodstream within three weeks, compared to around 15 percent of those who did not.
Researchers say they are now testing whether the procedure will help treat the chronic viral disease.
They are also testing whether it will reduce recurrences in patients who have the disease.
This procedure is still in the research stage, so it is not clear if the procedure could lead to new and better treatments for chronic viral disorders, like MRSA.
The University at Barbados, a small Caribbean island, has the highest rate of rhinoblastoma, or non-Hodgkin lymphoma, in the world, according the World Health Organization.
For more on the rhino horn trade, visit the U.S. Fish and Wildlife Service website.